Baxter International BAX
NYSE BAX
$26.34 -0.07 (-0.27%)
At close: Aug 21, 2026 · 4:00 PM EDT

Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024)

Baxter International (BAX) posted quarterly Income from Non-Controlling Interests of $2.0 million for Q4 2024, up 100.0% year-over-year from $1.0 million in Q1 2024, and down 50.0% quarter-over-quarter from $4.0 million in Q3 2024.

Baxter International (BAX) Income from Non-Controlling Interests (2009 - 2024) Analysis & Trends

Baxter International (BAX) has reported Income from Non-Controlling Interests for 9 consecutive years, with $2.0 million the latest figure, recorded in Q4 2024.

  • In Q4 2024, Income from Non-Controlling Interests rose 100.0% year-over-year to $2.0 million; the TTM figure through Sep 2025 stood at $2.0 million (down 50.0% YoY), while the FY2024 annual figure was $11.0 million, up 57.14% from the prior year.
  • Income from Non-Controlling Interests slipped to $2.0 million in Q4 2024 per BAX's latest filing, from $4.0 million in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $4.0 million in Q4 2021 and bottomed at -$4.0 million in Q1 2024.
  • Historically, Income from Non-Controlling Interests has averaged $2.2 million across 5 years, with a median of $2.5 million in 2020.
  • Annual changes were most pronounced in 2021 — Income from Non-Controlling Interests jumped 200.0% — and 2024, when it sank 500.0%.
  • Baxter International's Income from Non-Controlling Interests stood at $3.0 million in 2020, then jumped by 33.33% to $4.0 million in 2021, then changed by 0.0% to $4.0 million in 2022, then slumped by 75.0% to $1.0 million in 2023, then surged by 100.0% to $2.0 million in 2024.
  • Business Quant data shows BAX's Income from Non-Controlling Interests at $2.0 million in Q4 2024, $4.0 million in Q3 2024, and $3.0 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 6.60 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn -
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn -
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 79.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn -
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn -
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn -
10 Align Technology 11.61 Bn 10.51 Bn 757.43 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.00 Mn
Mar 31, 2024 2.00 Mn
Dec 31, 2023 -6.00 Mn
Sep 30, 2023 3.00 Mn
Jun 30, 2023 2.00 Mn
Mar 31, 2023 1.00 Mn
Dec 31, 2022 4.00 Mn
Sep 30, 2022 3.00 Mn
Jun 30, 2022 3.00 Mn
Mar 31, 2022 2.00 Mn
Dec 31, 2021 4.00 Mn
Sep 30, 2021 2.00 Mn
Jun 30, 2021 3.00 Mn
Mar 31, 2021 2.00 Mn
Dec 31, 2020 3.00 Mn
Sep 30, 2020 3.00 Mn
Jun 30, 2020 1.00 Mn
Mar 31, 2020 1.00 Mn
Dec 31, 2019 4.00 Mn
Sep 30, 2019 6.00 Mn